Advisors Asset Management Inc. decreased its stake in shares of TC Energy Co. (NYSE:TRP) (TSE:TRP) by 7.9% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,118 shares of the pipeline company's stock after sellin
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares saw a handy gain on Thursday after the U.S. Food and Drug Administration (FDA) gave the nod to Vertexs cystic fibrosis (CF) treatment. Essentially, the FDA approved Kalydeco (ivacaftor) to include use in children diagnosed with CF ages 12 to 24 months who have at least one mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene.
This FDA approval is based on data from the ongoing Phase 3 study (ARRIVAL) of 25 children with CF aged 12 to 24 months who have one of 10 mutations in the CFTR gene. The study demonstrated....More>>>
Unitedhealth Group Inc (NYSE:UNH)Q12019 Earnings CallApril 16, 2019, 8:45 a.m. ET
Prepared Remarks Questions and Answers Call Participants
Good morning and welcome to the UnitedHealth Group First Quarter 2019 Earnings Conference Call. A question-and-answer session will follow UnitedHealth Group’s prepared remarks. As a reminder, this call is being recorded.
Here are some important introductory information. This call contains forward-looking statements under the US federal securities....More>>>
The biotech industry has been in focus over the past week with pipeline and regulatory updates. The development of antibodies and vaccines for COVID-19 continues to grab spotlight as the pandemic rages on.
FibroGen, Inc. (FGEN Quick QuoteFGEN ) along with its Japan-based partner Astellas announced that the European Commission (“EC”) has approved roxadustat to treat adult patients with symptomatic anemia associated with chronic kidney disease (“CKD”). The drug will